
TOKYO, Sep 11, 2020 - (JCN Newswire) - Eisai Co., Ltd. announced today that a series of abstracts will be presented at the European Society for Medical Oncology (ESMO) Virtual Congress 2020 from September 19 to 21, 2020. The abstracts highlight updates regarding Eisai's in-house discovered LENVIMA (lenvatinib mesylate, the orally available kinase...
Read more: Eisai to Present Abstracts on Oncology Products and Pipeline at ESMO Virtual Congress 2020